All Posts: News Release
-
Acclaimed Breast Oncologist/Researcher Returns to Georgetown’s Cancer Center
Physician-scientist Marc E. Lippman, MD, MACP, FRCP, rejoins Georgetown Lombardi Comprehensive Cancer Center as a member of the breast cancer program and will also be a professor in the departments of oncology and medicine at Georgetown University Medical Center.
Category: News Release
-
Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options
Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.
Category: News Release
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
A team of researchers led by Georgetown Lombardi Comprehensive Cancer Center has published a study that indicates that the most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought.
Category: News Release
-
Georgetown Lombardi’s Jeffrey Toretsky, MD, Named a National Academy of Inventors Fellow
The National Academy of Inventors has named Jeffrey Toretsky, MD, a pediatric oncologist and researcher at Georgetown Lombardi Comprehensive Cancer Center, to its 2017 class of fellows.
Category: News Release
-
New Test Provides Accurate Measure of DNA Damage from Chemical Compounds
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Category: News Release
-
Clarivate Analytics and Georgetown University Named a USPTO Cancer Moonshot Challenge Winner
Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters today announced its third place win with Georgetown University in the USPTO Cancer Moonshot Challenge held by the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO).
Category: News Release
-
Chris Mortensen to Receive the 2016 NFLPA Georgetown Lombardi Award
Award-winning ESPN journalist Chris Mortensen has been named this year’s NFL Players Association Georgetown Lombardi Award honoree. Mortensen and his courageous battle against cancer will be recognized at the 30th Anniversary Lombardi Gala on October 29 in Washington, D.C.
Category: News Release
-
Inhibiting Production of One Protein Restores Treatment Benefit in Resistant Breast Cancer
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.
Category: News Release